These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19831380)
1. Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations. Huang X; Gu HH; Zhan CG J Phys Chem B; 2009 Nov; 113(45):15057-66. PubMed ID: 19831380 [TBL] [Abstract][Full Text] [Related]
2. Insights from molecular dynamics: the binding site of cocaine in the dopamine transporter and permeation pathways of substrates in the leucine and dopamine transporters. Merchant BA; Madura JD J Mol Graph Model; 2012 Sep; 38():1-12. PubMed ID: 23079638 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of Zn2+ on the kinetics and cocaine inhibition of dopamine transport by the human and rat dopamine transporters. Bjorklund NL; Volz TJ; Schenk JO Eur J Pharmacol; 2007 Jun; 565(1-3):17-25. PubMed ID: 17408612 [TBL] [Abstract][Full Text] [Related]
4. Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogs. Krout D; Pramod AB; Dahal RA; Tomlinson MJ; Sharma B; Foster JD; Zou MF; Boatang C; Newman AH; Lever JR; Vaughan RA; Henry LK Biochem Pharmacol; 2017 Oct; 142():204-215. PubMed ID: 28734777 [TBL] [Abstract][Full Text] [Related]
6. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter. Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648 [TBL] [Abstract][Full Text] [Related]
7. Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation. Dehnes Y; Shan J; Beuming T; Shi L; Weinstein H; Javitch JA Neurochem Int; 2014 Jul; 73():4-15. PubMed ID: 24576496 [TBL] [Abstract][Full Text] [Related]
8. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005 [TBL] [Abstract][Full Text] [Related]
9. Interaction of tyrosine 151 in norepinephrine transporter with the 2β group of cocaine analog RTI-113. Hill ER; Huang X; Zhan CG; Ivy Carroll F; Gu HH Neuropharmacology; 2011; 61(1-2):112-20. PubMed ID: 21420984 [TBL] [Abstract][Full Text] [Related]
10. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties. Schmitt KC; Zhen J; Kharkar P; Mishra M; Chen N; Dutta AK; Reith ME J Neurochem; 2008 Nov; 107(4):928-40. PubMed ID: 18786172 [TBL] [Abstract][Full Text] [Related]
11. Effects of cocaine and repeated cocaine followed by withdrawal. Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition. Meiergerd SM; McElvain JS; Schenk JO Biochem Pharmacol; 1994 Apr; 47(9):1627-34. PubMed ID: 8185677 [TBL] [Abstract][Full Text] [Related]
12. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740 [TBL] [Abstract][Full Text] [Related]
13. Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine. Heal DJ; Gosden J; Smith SL Neuropharmacology; 2014 Dec; 87():19-40. PubMed ID: 24953830 [TBL] [Abstract][Full Text] [Related]
14. Identification of a New Allosteric Binding Site for Cocaine in Dopamine Transporter. Xu L; Chen LY J Chem Inf Model; 2020 Aug; 60(8):3958-3968. PubMed ID: 32649824 [TBL] [Abstract][Full Text] [Related]
15. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter. Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483 [TBL] [Abstract][Full Text] [Related]
16. Structure of the human dopamine transporter in complex with cocaine. Nielsen JC; Salomon K; Kalenderoglou IE; Bargmeyer S; Pape T; Shahsavar A; Loland CJ Nature; 2024 Aug; 632(8025):678-685. PubMed ID: 39112703 [TBL] [Abstract][Full Text] [Related]
17. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice. Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881 [TBL] [Abstract][Full Text] [Related]
18. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain. Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. Zhu J; Yuan Y; Midde NM; Gomez AM; Sun WL; Quizon PM; Zhan CG J Neurovirol; 2016 Jun; 22(3):282-92. PubMed ID: 26501780 [TBL] [Abstract][Full Text] [Related]
20. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]